• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Japan Non Invasive Prenatal Testing Market

    ID: MRFR/HC/49124-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    Japan Non-Invasive Prenatal Testing Market Research Report By Test Type (Cell-Free DNA Testing, Biochemical Testing, Combined Screening), By Application (Fetal Gender Determination, Chromosomal Abnormalities Screening, Rhesus Disease Screening), By Technology (Next Generation Sequencing, Microarray Analysis, Polymerase Chain Reaction) and By End User (Hospitals, Diagnostic Laboratories, Direct-to-Consumer Companies)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Japan Non Invasive Prenatal Testing Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Japan Non Invasive Prenatal Testing Market Summary

    The Japan Non-Invasive Prenatal Testing market is poised for substantial growth, projected to reach 210 million USD by 2035.

    Key Market Trends & Highlights

    Japan Non-Invasive Prenatal Testing Key Trends and Highlights

    • The market valuation for Non-Invasive Prenatal Testing in Japan is estimated at 75.8 million USD in 2024.
    • From 2025 to 2035, the market is expected to grow at a compound annual growth rate of 9.71 percent.
    • By 2035, the market is anticipated to expand significantly, reaching a total value of 210 million USD.
    • Growing adoption of Non-Invasive Prenatal Testing due to increasing awareness of prenatal health is a major market driver.

    Market Size & Forecast

    2024 Market Size 75.8 (USD Million)
    2035 Market Size 210 (USD Million)
    CAGR (2025-2035) 9.71%

    Major Players

    Engaging Science, NIPD Genetics, LabCorp, Quest Diagnostics, Fulgent Genetics, MediGene, PerkinElmer, BGI, Illumina, Mayo Clinic, Roche, Natera, Cleveland Clinic, Thermo Fisher Scientific

    Japan Non Invasive Prenatal Testing Market Trends

    The Japan Non-Invasive Prenatal Testing Market is experiencing notable growth driven by an increasing awareness of maternal health and advancements in genetic testing technology. The preference for non-invasive procedures among expectant parents, combined with the accuracy of these tests, has led to greater adoption. 

    With Japan's aging population and rising maternal age, there is a growing demand for safe testing options that minimize risks to both the mother and the fetus. Additionally, the emphasis on preventative healthcare and early diagnosis is encouraging healthcare providers and patients to opt for non-invasive prenatal testing as a reliable option.There are several opportunities to be explored in this market. 

    The integration of Artificial Intelligence in prenatal testing could enhance the efficiency and accuracy of the tests, thus attracting more healthcare providers and patients. Expanding educational campaigns and awareness initiatives about the benefits and capabilities of non-invasive testing can also help in reaching a broader audience. Furthermore, increasing collaboration between leading diagnostic companies and healthcare institutions may accelerate innovation and improve access to these testing services across Japan. 

    Japan Non Invasive Prenatal Testing Market Drivers

    Market Segment Insights

    Japan Non-Invasive Prenatal Testing Market Segment Insights

    Japan Non-Invasive Prenatal Testing Market Segment Insights

    Non-Invasive Prenatal Testing Market Test Type Insights

    Non-Invasive Prenatal Testing Market Test Type Insights

    The Japan Non-Invasive Prenatal Testing Market showcases a diverse range of testing methodologies that are critical for prenatal screening, with the Test Type segment comprising notable methodologies such as Cell-Free DNA Testing, Biochemical Testing, and Combined Screening. Cell-Free DNA Testing has emerged as a prominent choice due to its high sensitivity and specificity in detecting chromosomal abnormalities, making it particularly vital for expectant mothers seeking early and accurate information about fetal health. 

    In the context of Japan, where advanced technology and healthcare innovation are paramount, this testing method aligns well with the preferences of healthcare providers and patients seeking more reliable options.On the other hand, Biochemical Testing plays an important role in the risk assessment of fetal anomalies by measuring specific biomarkers in maternal blood. 

    This traditional approach continues to hold significance in Japan’s healthcare system, particularly among practitioners who value its cost-effectiveness and ease of integration into routine prenatal care. Additionally, Combined Screening provides a comprehensive evaluation through the integration of biochemical markers and sonographic findings, delivering a well-rounded assessment to expectant parents.

    Given Japan’s aging population and increased prenatal awareness, the demand for these testing methods is projected to rise significantly, leading to enhanced prenatal care strategies. Moreover, the cultural emphasis on family health in Japan fortifies the importance of accurate and non-invasive testing, encouraging further research and innovations in this domain. Overall, the segmentation of the Japan Non-Invasive Prenatal Testing Market into these Test Types reflects an adaptive healthcare landscape responsive to both technological advancements and the evolving needs of prospective parents.

    Non-Invasive Prenatal Testing Market Application Insights

    Non-Invasive Prenatal Testing Market Application Insights

    The Japan Non-Invasive Prenatal Testing Market is gaining traction, particularly within the Application segment, which encompasses multiple key areas. Fetal Gender Determination is increasingly popular as parents today prioritize early knowledge about their baby's gender, thereby influencing preparations and decisions. Chromosomal Abnormalities Screening is significant, as it provides critical insights into potential genetic conditions, helping families make informed choices regarding their pregnancy. 

    This aspect resonates with Japan's strong emphasis on maternal and child health, leading to an increase in demand for such testing methodologies.Rhesus Disease Screening is essential in preventing complications during pregnancy, especially for Rh-negative mothers. Given Japan's aging population, the relevance of such screenings is heightened as older expectant mothers face increased risks. 

    Overall, the Application segment plays a crucial role in the Japan Non-Invasive Prenatal Testing Market, aligning closely with societal needs and healthcare advancements, thereby supporting healthy pregnancy outcomes while catering to the rising demand for maternal medical solutions.

    Non-Invasive Prenatal Testing Market Technology Insights

    Non-Invasive Prenatal Testing Market Technology Insights

    The Technology segment of the Japan Non-Invasive Prenatal Testing Market encompasses several advanced methodologies such as Next Generation Sequencing, Microarray Analysis, and Polymerase Chain Reaction, which play pivotal roles in genetic diagnostics. Next Generation Sequencing has gained significant importance due to its high throughput and accuracy in identifying genetic abnormalities, thus facilitating informed decision-making for expecting parents. 

    Microarray Analysis, on the other hand, allows for the comprehensive detection of chromosomal abnormalities by analyzing multiple genes simultaneously, making it essential for understanding complex genetic disorders.Polymerase Chain Reaction is crucial for amplifying specific DNA sequences, enabling the detection of certain genetic traits with high sensitivity. The adoption of these technologies is driven by increasing awareness of prenatal genetic testing and rising demand for early and accurate detection of genetic disorders. 

    Japan's regulatory framework promotes the integration of cutting-edge technologies in healthcare, fostering innovation and enhancing the capability of prenatal testing. This overall advancement signifies a growing trend towards personalized medicine, contributing positively to the Japan Non-Invasive Prenatal Testing Market statistics and growth trajectory, indicating promising opportunities for industry stakeholders.

    Non-Invasive Prenatal Testing Market End User Insights

    Non-Invasive Prenatal Testing Market End User Insights

    The Japan Non-Invasive Prenatal Testing Market showcases significant engagement from various end users, prominently including Hospitals, Diagnostic Laboratories, and Direct-to-Consumer Companies. Hospitals continue to play a crucial role as primary providers of prenatal care, offering advanced screening technologies to expectant mothers. They facilitate access to reliable testing options that enhance prenatal care quality. Diagnostic Laboratories are essential in the ecosystem, as they specialize in the processing and analysis of prenatal samples, ensuring accurate and timely results that inform clinical decisions.This specialization supports the rising demand for effective prenatal testing solutions that are vital for maternal and fetal health. 

    Meanwhile, Direct-to-Consumer Companies are emerging as significant players as they provide accessible and personalized testing options directly to pregnant individuals, empowering them with information about their prenatal health without intermediary processes. The collaborative dynamics among these end users illustrate a comprehensive approach to prenatal testing, responding to evolving consumer needs while aligning with Japan's healthcare standards that emphasize patient-centered care and technological advancement.Overall, the collective capacity of these end users drives substantial growth prospects within the Japan Non-Invasive Prenatal Testing Market landscape.

    Get more detailed insights about Japan Non Invasive Prenatal Testing Market Research Report - Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The Japan Non-Invasive Prenatal Testing Market is characterized by a competitive landscape that includes a variety of players, each vying for market share through innovation and strategic positioning. The market has witnessed significant advancements in technology, allowing for early detection of genetic conditions in fetuses with minimal risk to the mother. Companies are focusing on enhancing their product offerings with advanced genetic testing methodologies and expanding their service portfolios to cater to various healthcare providers. 

    The competitive dynamics are influenced by several factors including regulatory environments, consumer demand for accuracy in prenatal screening, and the ongoing research and development efforts by key market participants. Companies are also exploring partnerships and collaborations to strengthen their market positions and enhance their technological capabilities as they seek to address the evolving needs of healthcare practitioners and expecting parents.Engaging Science has made significant inroads in the Japan Non-Invasive Prenatal Testing Market through its commitment to delivering high-quality testing solutions. 

    The company is recognized for its unique approach to prenatal screening, combining state-of-the-art technological advancements with a focus on customer satisfaction. Engaging Science rapidly established a presence in Japan and is often lauded for its comprehensive suite of non-invasive prenatal tests that are deemed to be reliable and efficient. The company’s strengths lie in its excellent research capabilities and robust quality assurance processes, which contribute to the confidence healthcare providers place in its products. Engaging Science has also prioritized education and awareness programs, ensuring that medical professionals are well-equipped to interpret test results accurately and counsel parents effectively.

    NIPD Genetics has carved out a significant position in the Japan Non-Invasive Prenatal Testing Market by focusing on personalized healthcare solutions and precise genetic testing services. The company offers a range of key products, including non-invasive prenatal tests that assess the risk of chromosomal abnormalities and other genetic conditions. NIPD Genetics’ market presence in Japan is bolstered by its strong commitment to research and development, allowing it to stay at the forefront of innovations in genetic testing. 

    The company has solidified its strengths through strategic partnerships with healthcare institutions and advancements in laboratory technologies that enhance testing accuracy and turnaround times. Moreover, NIPD Genetics has engaged in collaborations and mergers that have helped expand its reach and service offerings within Japan, thereby reinforcing its competitive edge in the highly dynamic market for prenatal testing solutions.

    Key Companies in the Japan Non Invasive Prenatal Testing Market market include

    Industry Developments

    The Japan Non-Invasive Prenatal Testing Market has seen various developments recently, particularly with advancements in genetic testing technologies. In October 2023, BGI announced the expansion of its testing services to incorporate whole genome sequencing, enhancing detection rates for chromosomal abnormalities. Companies like Fulgent Genetics and Illumina have also been investing in local partnerships to improve service accessibility.

    In terms of mergers and acquisitions, LabCorp acquired a majority stake in a Tokyo-based diagnostic firm in September 2023, aimed at bolstering its presence in the Japanese market. This move is anticipated to enhance LabCorp's capabilities in delivering genetic testing services.Additionally, there has been a steady rise in adoption rates for non-invasive prenatal tests among expectant mothers in Japan, as reported by national health authorities in early 2023, highlighting a growing awareness of the benefits of these tests. Companies such as Natera and Quest Diagnostics are actively engaging government health departments to promote these tests, leading to improved healthcare outcomes.

    The overall market dynamics reflect an increasing collaboration among key players, focusing on technological advancements and patient accessibility, shaping the future of prenatal care in Japan.

    Market Segmentation

    Outlook

    • Hospitals
    • Diagnostic Laboratories
    • Direct-to-Consumer Companies

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 75.75(USD Million)
    MARKET SIZE 2024 82.5(USD Million)
    MARKET SIZE 2035 210.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.865% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Engaging Science, NIPD Genetics, LabCorp, Quest Diagnostics, Fulgent Genetics, MediGene, PerkinElmer, BGI, Illumina, Mayo Clinic, Roche, Natera, Cleveland Clinic, Thermo Fisher Scientific
    SEGMENTS COVERED Test Type, Application, Technology, End User
    KEY MARKET OPPORTUNITIES Increased awareness of prenatal testing, Rising demand for early diagnosis, Expanding maternal age demographic, Technological advancements in testing, Growing healthcare investment trends
    KEY MARKET DYNAMICS Growing awareness of prenatal health, Increasing maternal age, Advancements in testing technology, Rising prevalence of genetic disorders, Expanding reimbursement policies
    COUNTRIES COVERED Japan

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the projected market value of the Japan Non-Invasive Prenatal Testing Market in 2024?

    The Japan Non-Invasive Prenatal Testing Market is expected to be valued at 82.5 million USD in 2024.

    What is the expected market value of the Japan Non-Invasive Prenatal Testing Market in 2035?

    The market is projected to reach a valuation of 210.0 million USD by 2035.

    What is the expected compound annual growth rate (CAGR) for the Japan Non-Invasive Prenatal Testing Market from 2025 to 2035?

    The expected CAGR for the market is 8.865% during the period from 2025 to 2035.

    What are the key segments by test type within the Japan Non-Invasive Prenatal Testing Market?

    The market is segmented into Cell-Free DNA Testing, Biochemical Testing, and Combined Screening.

    What is the market value of Cell-Free DNA Testing in 2024?

    Cell-Free DNA Testing is valued at 40.0 million USD in 2024.

    What is the market value of Biochemical Testing in 2024?

    The Biochemical Testing segment is expected to be valued at 25.0 million USD in 2024.

    What is the market value of Combined Screening in 2024?

    Combined Screening is projected to have a market value of 17.5 million USD in 2024.

    Who are the major players in the Japan Non-Invasive Prenatal Testing Market?

    Key players include Engaging Science, NIPD Genetics, LabCorp, Quest Diagnostics, and Illumina among others.

    What is the expected market value for Cell-Free DNA Testing in 2035?

    By 2035, Cell-Free DNA Testing is expected to reach a market value of 100.0 million USD.

    What emerging trends are influencing the growth of the Japan Non-Invasive Prenatal Testing Market?

    Key trends include advancements in technology, increasing awareness, and rising demand for accurate prenatal screening.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. Japan Non-Invasive Prenatal Testing Market, BY Test Type (USD Million)
    45. Cell-Free DNA Testing
    46. Biochemical Testing
    47. Combined Screening
    48. Japan Non-Invasive Prenatal Testing Market, BY Application (USD Million)
    49. Fetal Gender Determination
    50. Chromosomal Abnormalities Screening
    51. Rhesus Disease Screening
    52. Japan Non-Invasive Prenatal Testing Market, BY Technology (USD Million)
    53. Next Generation Sequencing
    54. Microarray Analysis
    55. Polymerase Chain Reaction
    56. Japan Non-Invasive Prenatal Testing Market, BY End User (USD Million)
    57. Hospitals
    58. Diagnostic Laboratories
    59. Direct-to-Consumer Companies
    60. Competitive Landscape
    61. Overview
    62. Competitive Analysis
    63. Market share Analysis
    64. Major Growth Strategy in the Non-Invasive Prenatal Testing Market
    65. Competitive Benchmarking
    66. Leading Players in Terms of Number of Developments in the Non-Invasive Prenatal Testing Market
    67. Key developments and growth strategies
    68. New Product Launch/Service Deployment
    69. Merger & Acquisitions
    70. Joint Ventures
    71. Major Players Financial Matrix
    72. Sales and Operating Income
    73. Major Players R&D Expenditure. 2023
    74. Company Profiles
    75. Engaging Science
    76. Financial Overview
    77. Products Offered
    78. Key Developments
    79. SWOT Analysis
    80. Key Strategies
    81. NIPD Genetics
    82. Financial Overview
    83. Products Offered
    84. Key Developments
    85. SWOT Analysis
    86. Key Strategies
    87. LabCorp
    88. Financial Overview
    89. Products Offered
    90. Key Developments
    91. SWOT Analysis
    92. Key Strategies
    93. Quest Diagnostics
    94. Financial Overview
    95. Products Offered
    96. Key Developments
    97. SWOT Analysis
    98. Key Strategies
    99. Fulgent Genetics
    100. Financial Overview
    101. Products Offered
    102. Key Developments
    103. SWOT Analysis
    104. Key Strategies
    105. MediGene
    106. Financial Overview
    107. Products Offered
    108. Key Developments
    109. SWOT Analysis
    110. Key Strategies
    111. PerkinElmer
    112. Financial Overview
    113. Products Offered
    114. Key Developments
    115. SWOT Analysis
    116. Key Strategies
    117. BGI
    118. Financial Overview
    119. Products Offered
    120. Key Developments
    121. SWOT Analysis
    122. Key Strategies
    123. Illumina
    124. Financial Overview
    125. Products Offered
    126. Key Developments
    127. SWOT Analysis
    128. Key Strategies
    129. Mayo Clinic
    130. Financial Overview
    131. Products Offered
    132. Key Developments
    133. SWOT Analysis
    134. Key Strategies
    135. Roche
    136. Financial Overview
    137. Products Offered
    138. Key Developments
    139. SWOT Analysis
    140. Key Strategies
    141. Natera
    142. Financial Overview
    143. Products Offered
    144. Key Developments
    145. SWOT Analysis
    146. Key Strategies
    147. Cleveland Clinic
    148. Financial Overview
    149. Products Offered
    150. Key Developments
    151. SWOT Analysis
    152. Key Strategies
    153. Thermo Fisher Scientific
    154. Financial Overview
    155. Products Offered
    156. Key Developments
    157. SWOT Analysis
    158. Key Strategies
    159. References
    160. Related Reports
    161. Japan Non-Invasive Prenatal Testing Market SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD Billions)
    162. Japan Non-Invasive Prenatal Testing Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    163. Japan Non-Invasive Prenatal Testing Market SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD Billions)
    164. Japan Non-Invasive Prenatal Testing Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)
    165. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    166. ACQUISITION/PARTNERSHIP
    167. MARKET SYNOPSIS
    168. JAPAN NON-INVASIVE PRENATAL TESTING MARKET ANALYSIS BY TEST TYPE
    169. JAPAN NON-INVASIVE PRENATAL TESTING MARKET ANALYSIS BY APPLICATION
    170. JAPAN NON-INVASIVE PRENATAL TESTING MARKET ANALYSIS BY TECHNOLOGY
    171. JAPAN NON-INVASIVE PRENATAL TESTING MARKET ANALYSIS BY END USER
    172. KEY BUYING CRITERIA OF NON-INVASIVE PRENATAL TESTING MARKET
    173. RESEARCH PROCESS OF MRFR
    174. DRO ANALYSIS OF NON-INVASIVE PRENATAL TESTING MARKET
    175. DRIVERS IMPACT ANALYSIS: NON-INVASIVE PRENATAL TESTING MARKET
    176. RESTRAINTS IMPACT ANALYSIS: NON-INVASIVE PRENATAL TESTING MARKET
    177. SUPPLY / VALUE CHAIN: NON-INVASIVE PRENATAL TESTING MARKET
    178. NON-INVASIVE PRENATAL TESTING MARKET, BY TEST TYPE, 2025 (% SHARE)
    179. NON-INVASIVE PRENATAL TESTING MARKET, BY TEST TYPE, 2019 TO 2035 (USD Billions)
    180. NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2025 (% SHARE)
    181. NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    182. NON-INVASIVE PRENATAL TESTING MARKET, BY TECHNOLOGY, 2025 (% SHARE)
    183. NON-INVASIVE PRENATAL TESTING MARKET, BY TECHNOLOGY, 2019 TO 2035 (USD Billions)
    184. NON-INVASIVE PRENATAL TESTING MARKET, BY END USER, 2025 (% SHARE)
    185. NON-INVASIVE PRENATAL TESTING MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    186. BENCHMARKING OF MAJOR COMPETITORS

    Japan Non-Invasive Prenatal Testing Market Segmentation

     

     

     

    • Non-Invasive Prenatal Testing Market By Test Type (USD Million, 2019-2035)

      • Cell-Free DNA Testing
      • Biochemical Testing
      • Combined Screening

     

    • Non-Invasive Prenatal Testing Market By Application (USD Million, 2019-2035)

      • Fetal Gender Determination
      • Chromosomal Abnormalities Screening
      • Rhesus Disease Screening

     

    • Non-Invasive Prenatal Testing Market By Technology (USD Million, 2019-2035)

      • Next Generation Sequencing
      • Microarray Analysis
      • Polymerase Chain Reaction

     

    • Non-Invasive Prenatal Testing Market By End User (USD Million, 2019-2035)

      • Hospitals
      • Diagnostic Laboratories
      • Direct-to-Consumer Companies

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027